Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease

Clinical and Experimental Immunology

Volumn 160, Issue 3, 2010, Pages 457-460

  Fujita, M ^a,b   Harada, E ^a   Matsumoto, T ^b   Mizuta, Y ^a   Ikegame, S ^a   Ouchi, H ^a   Inoshima, I ^a   Yoshida, S ^a   Watanabe, K ^b   Nakanishi, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Animal study; Innate immunity; Mycobacteriosis; NADPH oxidase; Opportunistic infection

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; HOST RESISTANCE; LUNG INFECTION; MACROPHAGE; MORTALITY; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SURVIVAL RATE;

ANIMALS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; IMMUNITY, INNATE; MACROPHAGES, PERITONEAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MYCOBACTERIUM AVIUM; NADP; NADPH OXIDASE; TUBERCULOSIS, PULMONARY;

EID: 77952169476     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04092.x     Document Type: Article

References (23)

1. Medical Section of the American Lung Association. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997 156 : S1 25.
2. Griffith DE, Aksamit T, Brown-Elliott BA et al., ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007 175 : 367 416. (Pubitemid 46271561)
3. Wallace RJ Jr., Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients. Am J Respir Crit Care Med 1996 153 : 1766 1772. (Pubitemid 26187897)
4. Griffith DE, Brown BA, Girard WM, Griffith BE, Couch LA, Wallace RJ Jr. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. Clin Infect Dis 2001 32 : 1547 1553. (Pubitemid 32458721)
5. Tanaka E, Kimoto T, Tsuyuguchi K et al. Effect of clarithromycin regimen for Mycobacteriuim avium complex pulmonary disease. Am J Respir Crit Care Med 1999 160 : 866 872. (Pubitemid 29442022)
6. Corpe RF. Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare. Rev Infect Dis 1981 3 : 1064 1067.
7. Moran JF, Alexander LG, Stauh EW, Young WG, Sealy WC. Long-term results of pulmonary resection for atypical mycobacterial disease. Am Thorac Surg 1983 35 : 597 604.
8. Lehrer RI. The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest 1975 55 : 338 346.
9. Washburn RG, Gallin JI, Bennett JE. Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways. Infect Immun 1987 55 : 2088 2092.
10. Pollock JD, Williams DA, Gifford MA et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995 9 : 202 209.
11. Fratazzi C, Manjunath N, Arbeit RD et al. A macrophage invasion mechanism for mycobacteria implicating the extracellular domain of CD43. J Exp Med 2000 192 : 183 192. (Pubitemid 30470301)
12. Saito M, Seki M, Iida K, Nakayama H, Yoshida S. A novel agar medium to detect hydrogen peroxide-producing bacteria based on the prussian blue-forming reaction. Microbiol Immunol 2007 51 : 889 892. (Pubitemid 47450486)
13. Fujita M, Ye Q, Ouchi H et al. Doxycycline attenuated pulmonary fibrosis induced by bleomycin in mice. Antimicrob Agents Chemother 2006 50 : 739 743. (Pubitemid 43190990)
14. Yoshida S, Goto Y, Mizuguchi Y, Nomoto K, Skamene E. Genetic control of natural resistance in mouse macrophages regulating intracellular Legionella pneumophila multiplication in vitro. Infect Immun 1991 59 : 428 432.
15. Fujita M, Ikegame S, Harada E et al. TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in mice. Cytokine 2008 44 : 298 303.
16. Salyers AA. A molecular approach. In : Whitt DD, ed. Bacterial pathogenesis, 2nd edn.
17. Rossi F, Della Bianca V, de Togni P. Mechanisms and functions of the oxygen radicals producing respiration of phagocytes. Comp Immunol Microbiol Infect Dis 1985 8 : 187 204. (Pubitemid 16203331)
18. Jones GS, Amirault HJ, Andersen BR. Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis 1990 162 : 700 704. (Pubitemid 20266162)
19. Lee PP, Chan KW, Jiang L et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J 2008 27 : 224 230.
20. Ohga S, Ikeuchi K, Kadoya R et al. Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease. J Infect 1997 34 : 147 150. (Pubitemid 27182777)
21. Kusuhara K, Ohga S, Hoshina T et al. Disseminated bacillus Calmette-Guérin lymphadenitis in a patient with gp91phox - chronic granulomatous disease 25 years after vaccination. Eur J Pediatr 2009 168 : 745 747.
22. Segal BH, Doherty TM, Wynn TA, Cheever AW, Sher A, Holland SM. The p47(phox-/-) mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs. Infect Immun 1999 67 : 1659 1665. (Pubitemid 29144379)
23. Adams LB, Dinauer MC, Morgenstern DE, Krahenbuhl JL. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber Lung Dis 1997 78 : 237 246.